-
EC's von der Leyen loses bid to stop disclosure of Pfizer texts
14 May 2025 13:58 GMT
European Commission President Ursula von der Leyen has lost a lawsuit attempting to force her to disclose text messages with Pfizer chief executive Albert Bourla on COVID-19 vaccine procurement at the height of the pandemic.
Judges at the EU's General …
-
Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals
14 May 2025 00:42 GMT
… easily be considered a ‘mini-Pfizer.’
And it has the … re a lot smaller [than Pfizer] obviously,” Atkinson was quick to … bills itself as a ‘mini-Pfizer,’ that should be becoming … a commercial relationship with AFT Pharmaceuticals at the time this article …
-
Saudi Arabia Active Pharmaceutical Ingredients Market Forecasts & Opportunities Report 2024-2025 & 2030 Featuring Pfizer, Aurobindo Pharma, Novartis, BASF, Viatris, And Novo Nordisk
13 May 2025 10:17 GMT
(MENAFN- GlobeNewsWire - Nasdaq) The Active Pharmaceutical Ingredients (API) market in Saudi Arabia is a critical segment of the country's pharmaceutical industry, which is experiencing notable expansion. This growth is fueled by rising healthcare …
-
Saudi Arabia Pharmaceutical CDMO Market Research Report 2025 Featuring Tabuk Manufacturing, Lifera, Saudi Bio, Fresenius Kabi, Hikma Pharma, Pfizer, Novartis
13 May 2025 10:07 GMT
… by increased domestic demand for pharmaceuticals, driven by demographic changes … Fresenius Kabi MENA Hikma Pharmaceuticals PLC Pfizer Scientific Technical Limited Company … Fresenius Kabi MENA Hikma Pharmaceuticals PLC Pfizer Scientific Technical Limited …
-
US groups raced to stockpile pharmaceuticals ahead of tariffs
13 May 2025 05:47 GMT
… yet announced levies targeting the pharmaceuticals sector, but companies are preparing … presence in the US”, while Pfizer’s chief financial officer told … Trade Organization trade deal.
European pharmaceuticals companies are also boosting their …
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2025
12 May 2025 20:29 GMT
… patent infringement lawsuit against Pfizer.
Interest and investment income … June 21, 2022, against Pfizer, Inc. seeking damages … use and sale of Pfizer’s COVID-19 antiviral … 21,295
21,128
ENANTA PHARMACEUTICALS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS …
-
Examining shifts in clinical trial outsourcing
14 May 2025 21:18 GMT
… from organisations including Pfizer, Bristol Myers Squibb, Endo Pharmaceuticals, and Otsuka are …
-
Trump to sign executive order to reduce cost of prescription drugs and pharmaceuticals up to 80%
12 May 2025 02:18 GMT
… of prescription drugs and pharmaceuticals by up to 80 … wondered why Prescription Drugs and Pharmaceuticals in the United States … treatment Fasenra.
Increases for Pfizer included a six percent rise … daily by millions of Americans
Pfizer said the rises were …
-
In-Depth Analysis Of The Global Nerve Entrapment Syndrome Market: Key Drivers, Trends, Growth, And Forecast 2025-2034
14 May 2025 17:53 GMT
… are Pfizer Inc., Dr. Reddy’s Laboratories, Glenmark Pharmaceuticals, Athletico … Center, SPR Therapeutics, Centaur Pharmaceuticals, ProActive Physical Therapy & … Physio Tattva, InvaGen Pharmaceuticals Inc., WEX Pharmaceuticals Inc., Dogwood Therapeutics …
-
Paget Disease Treatment Market Forecast 2025-2034: Analyzing Growth Drivers, Market Share, Segments, And Emerging Trends
14 May 2025 17:53 GMT
The Business Research Company's Paget Disease Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- The Business Research Company’s …
About
© 1995-2025